| Changes of Depression After First-year of Tofacitinib in RA Patients (NCT03992781) | Pfizer | 2020-07-23 |
| A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled (NCT06282991) | Pfizer | 2020-07-22 |
| Study To Characterize Mass Balance, Absolute Bioavailability, Fraction Absorbed And Pharmacokinetics Of 14C PF-06882961 (NCT04495140) | Pfizer | 2020-07-22 |
| Study of Single and Multiple Ascending Doses of PF-07059013 in Healthy Adult Participants (NCT04323124) | Pfizer | 2020-07-17 |
| Besponsa Post Marketing Surveillance Study (NCT04307134) | Pfizer | 2020-07-09 |
| Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy (NCT04412252) | Pfizer | 2020-07-06 |
| Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients (NCT04398732) | Pfizer | 2020-07-05 |
| Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA) (NCT04428502) | Pfizer | 2020-07-05 |
| Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO). (NCT04428411) | Pfizer | 2020-07-05 |
| Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients (NCT04428424) | Pfizer | 2020-07-05 |
| Renal Impairment Study of PF-06700841 (NCT04260464) | Pfizer | 2020-07-03 |
| Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination Therapy (NCT04394247) | Pfizer | 2020-06-30 |
| Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine (NCT04408794) | Pfizer | 2020-06-29 |
| Study To Assess The Bioequivalence Under Fed And Fasted Conditions Of The Fesoterodine Beads-In-Capsule SR4 And SR7 Formulations And To Estimate The Bioavailability of SR7 Beads Sprinkled On Apple Sauce Relative To The Beads-In-Capsule SR7 Formulation Administer (NCT04452838) | Pfizer | 2020-06-26 |
| Study to Evaluate the Effect of Repeat-Dose Rifampin on the Pharmacokinetics (PK) of PF-06651600 (NCT04266509) | Pfizer | 2020-06-25 |
| A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy. (NCT04424316) | Pfizer | 2020-06-17 |
| MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age (NCT04440163) | Pfizer | 2020-06-17 |
| A Study In Adult Healthy Volunteers To Asses Once Daily (QD) Dosing With The Selected Age-Appropriate Modified Release (MR) Formulations (NCT04338711) | Pfizer | 2020-06-17 |
| A Trial to Describe the Safety and Immunogenicity of MenABCWY When Administered on 2 Schedules (NCT04440176) | Pfizer | 2020-06-17 |
| A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS. (NCT04355845) | Pfizer | 2020-06-15 |
| Single-dose PK Study of Ceftazidime-Avibactam In Hospitalized Children Receiving Systemic Antibiotics for Nosocomial Pneumonia (NCT04040621) | Pfizer | 2020-06-15 |
| Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) (NCT04321031) | Pfizer | 2020-06-15 |
| Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSV (NCT04267822) | Pfizer | 2020-06-15 |
| A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATIN IN NSCLC (NCT04325698) | Pfizer | 2020-06-11 |
| Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy (NCT04345367) | Pfizer | 2020-06-11 |
| NOAC Portuguese Real World Study (NCT04808934) | Pfizer | 2020-06-01 |
| 20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants (NCT04379713) | Pfizer | 2020-05-21 |
| 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants (NCT04382326) | Pfizer | 2020-05-20 |
| Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries (NCT04198571) | Pfizer | 2020-05-17 |
| Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients (NCT04071405) | Pfizer | 2020-05-12 |
| Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen (NCT04346615) | Pfizer | 2020-04-25 |
| A Study Of Treatment Patterns And Clinical Outcomes In Patients Diagnosed With Acute Myeloid Leukemia Who Received Mylotarg in the Real-World (NCT04337138) | Pfizer | 2020-04-07 |
| A Study Of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta Under Fed Conditions (NCT03794154) | Pfizer | 2020-03-30 |
| A Study of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta (NCT03729284) | Pfizer | 2020-03-30 |
| Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies (NCT04181788) | Pfizer | 2020-03-18 |
| Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus (NCT04305587) | Pfizer | 2020-03-16 |
| Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B (NCT03938792) | Pfizer | 2020-03-09 |
| Anaplastic Lymphoma Kinase (ALK)-Positive Non-small Cell Lung Cancer (NSCLC) Post-alectinib Treatment Patterns (NCT04351334) | Pfizer | 2020-03-01 |
| A Low Interventional Study to Monitor Activity Using Wearable Sensors in Duchenne Muscular Dystrophy (NCT04254172) | Pfizer | 2020-02-19 |
| Safety and Efficacy of Dexmedetomidine (DEX) for Sedation of Subjects ≥1 Month to <17 Years Undergoing MRI Scans (NCT04237792) | Pfizer | 2020-02-18 |
| A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BOOSTER DOSE OF A GROUP B STREPTOCOCCUS 6 VALENT POLYSACCHARIDE CONJUGATE VACCINE (GBS6) IN HEALTHY ADULTS (NCT04258995) | Pfizer | 2020-02-11 |
| Nonacog Alfa Prophylaxis And Treatment Of Bleeding Episodes In Previously Treated Patients With Hemophilia B (NCT04286412) | Pfizer | 2020-02-10 |
| A Drug-Drug Interaction Study To Estimate The Effect Of Tafamidis On Rosuvastatin Pharmacokinetics (NCT04253353) | Pfizer | 2020-02-06 |
| Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Hemophilia A Patients (NCT04396639) | Pfizer | 2020-01-25 |
| Special Investigation for VIZIMPRO Tablets (Secondary Data Collection Study; Safety and Efficacy of VIZIMPRO Under Japanese Medical Practice) (NCT04155541) | Pfizer | 2020-01-24 |
| A STUDY TO COMPARE THE PHARMACOKINETICS OF PF-06835919 IN PARTICIPANTS WITH AND WITHOUT HEPATIC IMPAIRMENT (NCT04193436) | Pfizer | 2020-01-21 |
| Hepatic Impairment Study for Lorlatinib in Cancer Patients (NCT03726333) | Pfizer | 2020-01-14 |
| Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants. (NCT04126031) | Pfizer | 2020-01-14 |
| A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis (NCT04230213) | Pfizer | 2020-01-13 |
| Dose Escalation Study to Evaluate the Safety, Tolerability, PK and PD of Voxelotor in Patients With SCD (NCT04247594) | Pfizer | 2020-01-09 |
| A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease (NCT04173273) | Pfizer | 2020-01-06 |
| InO - A Retrospective Study of UK Patients With Leukaemia (NCT04456959) | Pfizer | 2020-01-06 |
| A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer (NCT04165317) | Pfizer | 2019-12-30 |
| Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors (NCT04052204) | Pfizer | 2019-12-30 |
| REGISTRY OF COMPLETE RESPONSES TO SUNITINIB IN SPANISH PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (NCT03916458) | Pfizer | 2019-12-17 |
| A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With mRCC in Latin America (LA) (NCT04115189) | Pfizer | 2019-12-13 |
| Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC (NCT04375150) | Pfizer | 2019-12-02 |
| A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa (NCT04092452) | Pfizer | 2019-12-02 |
| Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors. (NCT04171141) | Pfizer | 2019-11-19 |
| LORA-PITA IV General Investigation (NCT03905798) | Pfizer | 2019-11-18 |
| The Effectiveness and Safety of Apixaban in NVAF Patients With History of Osteoporosis and/or Fracture: A Nation-wide Population Based Study (NCT04198844) | Pfizer | 2019-11-18 |
| HR+/ HER2- Advanced/ Metastatic Breast Cancer Real World Treatment Patterns and Outcomes (NCT04396626) | Pfizer | 2019-11-18 |
| Open-Label Extension of Voxelotor (NCT04188509) | Pfizer | 2019-11-18 |
| A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection. (NCT04225897) | Pfizer | 2019-11-13 |
| BIOEQUIVALENCE STUDY IN HEALTHY PARTICIPANTS COMPARING 4 MG AND 8 MG FESOTERODINE EXTENDED-RELEASE TABLETS (TOVIAZ™), MANUFACTURED AT ZWICKAU VERSUS FREIBURG (NCT04478357) | Pfizer | 2019-11-12 |
| Study of Single Ascending Doses of PF-07081532 in Healthy Adult Participants (NCT04148209) | Pfizer | 2019-11-05 |
| Clinical Outcomes For Patients With Metastatic Renal Cell Carcinoma (mRCC) Who Received Sunitinib After 1st Line Immune-oncology (IO) Treatments (NCT04175262) | Pfizer | 2019-10-31 |
| A Study To Determine The Safety, Tolerability, Skin Irritation Potential, And PK Following Topical Application Of PF-07038124 In Healthy Participants (NCT04135560) | Pfizer | 2019-10-29 |
| A Drug Drug Interaction Study Between PF-06826647 And Oral Contraceptive Steroids In Healthy Female Participants (NCT04134715) | Pfizer | 2019-10-23 |
| Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis) (NCT03885089) | Pfizer | 2019-10-21 |
| Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting. (NCT04460911) | Pfizer | 2019-10-19 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PF-06842874 in Healthy Participants (NCT04124653) | Pfizer | 2019-10-17 |
| A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus (NCT03985293) | Pfizer | 2019-10-15 |
| Study to Assess Pharmacokinetics, Safety and Tolerability of PF-04965842 in Chinese Healthy Participants (NCT04099563) | Pfizer | 2019-10-14 |
| A Study to Demonstrate the Equivalence of the Tofacitinib Oral Solution to the Tablet Formulation in Healthy Participants. (NCT04111614) | Pfizer | 2019-10-11 |
| Effect Of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of PF-06865571 In Subjects With Hepatic Impairment and in Healthy Subjects (NCT04091061) | Pfizer | 2019-10-03 |
| Vyndaqel Capsules Special Investigation (ATTR-CM) (NCT04108091) | Pfizer | 2019-10-03 |
| Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib. (NCT04033991) | Pfizer | 2019-09-27 |
| A Study of PF-06651600 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants (NCT04092595) | Pfizer | 2019-09-26 |
| A Study to Investigate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of PF-06700841 in Healthy Participants (NCT04090047) | Pfizer | 2019-09-24 |
| A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis (NCT04040192) | Pfizer | 2019-09-12 |
| An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis (NCT03950232) | Pfizer | 2019-09-05 |
| Patient-reported Outcomes in Subjects Treated With ReFacto AF Routine Prophylaxis (NCT02718677) | Pfizer | 2019-09-01 |
| Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor-2-negative (HR+/HER2-) Advanced Breast Cancer: An Analysis of Administrative Claims Data in Japan (NCT05153187) | Pfizer | 2019-08-31 |
| Effect of Multiple Doses of Modafinil on the Pharmacokinetics of Single Dose Lorlatinib in Healthy Participants (NCT03961997) | Pfizer | 2019-08-22 |
| A COHORT STUDY TO EVALUATE IMMUNOGENICITY FOR CHINESE CHILDREN AT THE TIME OF CLINICAL PNEUMONIA DIAGNOSIS (NCT05372575) | Pfizer | 2019-08-15 |
| Pharmacokinetics and Safety of RV521 Formulations (NCT04065698) | Pfizer | 2019-08-13 |
| Relative Bioavailability Study of a Modified-Release Formulation of PF-06865571 in Healthy Adult Participants (NCT04044053) | Pfizer | 2019-08-13 |
| Effect of PF-06651600 on the Pharmacokinetics of Oral Contraceptive Steroids (NCT04018274) | Pfizer | 2019-08-09 |
| Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy (NCT04309617) | Pfizer | 2019-07-31 |
| Precedex Special Investigation (in Pediatric Patients) (NCT04040439) | Pfizer | 2019-07-30 |
| A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B (NCT03861273) | Pfizer | 2019-07-29 |
| A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy (NCT03760029) | Pfizer | 2019-07-24 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of PF-06651600 in Subjects With Hepatic Impairment and Healthy Volunteers (NCT04016077) | Pfizer | 2019-07-19 |
| A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus (NCT03969719) | Pfizer | 2019-07-18 |
| Long-Term PF-06651600 for the Treatment of Alopecia Areata (NCT04006457) | Pfizer | 2019-07-18 |
| Study of Commercial and Phase 3 of PF-04965842 Formulations, Estimation of Effect of Food on Commercial Formulation (NCT04065633) | Pfizer | 2019-07-18 |
| Bioavailability Study of PF-06651600 Formulations in Healthy Participants (NCT04004663) | Pfizer | 2019-07-15 |
| Singe Dose Study of PF- 06946860 in Healthy Adult Japanese Participants (NCT03974776) | Pfizer | 2019-07-08 |
| Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML (NCT03727750) | Pfizer | 2019-07-03 |